NO963559L - Recombinant adenoviruses encoding brain-derived naurotrophic factor (BDNF) - Google Patents

Recombinant adenoviruses encoding brain-derived naurotrophic factor (BDNF)

Info

Publication number
NO963559L
NO963559L NO963559A NO963559A NO963559L NO 963559 L NO963559 L NO 963559L NO 963559 A NO963559 A NO 963559A NO 963559 A NO963559 A NO 963559A NO 963559 L NO963559 L NO 963559L
Authority
NO
Norway
Prior art keywords
naurotrophic
bdnf
factor
derived
recombinant adenoviruses
Prior art date
Application number
NO963559A
Other languages
Norwegian (no)
Inventor
Pascal Barneoud
Pia Delaere
Michel Perricaudet
Laurent Pradier
Emmanuelle Vigne
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO963559L publication Critical patent/NO963559L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO963559A 1994-03-18 1996-08-26 Recombinant adenoviruses encoding brain-derived naurotrophic factor (BDNF) NO963559L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9403191A FR2717496B1 (en) 1994-03-18 1994-03-18 Recombinant viruses, preparation and use in gene therapy.
PCT/FR1995/000250 WO1995025804A1 (en) 1994-03-18 1995-03-02 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf)

Publications (1)

Publication Number Publication Date
NO963559L true NO963559L (en) 1996-08-26

Family

ID=9461190

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963559A NO963559L (en) 1994-03-18 1996-08-26 Recombinant adenoviruses encoding brain-derived naurotrophic factor (BDNF)

Country Status (12)

Country Link
EP (1) EP0750676A1 (en)
JP (1) JPH09510358A (en)
KR (1) KR970701784A (en)
AU (1) AU703793B2 (en)
CA (1) CA2184200A1 (en)
FI (1) FI963674A0 (en)
FR (1) FR2717496B1 (en)
IL (1) IL112992A0 (en)
MX (1) MX9603490A (en)
NO (1) NO963559L (en)
WO (1) WO1995025804A1 (en)
ZA (1) ZA952244B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830857A (en) * 1995-07-14 1998-11-03 Amgen Inc. Method of treating epilepsy
FR2753379B1 (en) 1996-09-13 1998-10-30 Rhone Poulenc Rorer Sa METHOD OF TREATING AMYOTROPHIC SIDE SCLEROSIS
US7741310B2 (en) * 2000-05-05 2010-06-22 Research Foundation Of The City University Of New York Methods for stimulating nervous system regeneration and repair by regulating arginase I and polyamine synthesis
EP3755380A4 (en) * 2018-02-20 2021-12-08 Carmel-Haifa University Economic Corporation Ltd. Compositions and methods for delivery and expression of small inhibitory peptides and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993001300A1 (en) * 1991-07-10 1993-01-21 Regeneron Pharmaceuticals, Inc. Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules
US5733871A (en) * 1991-11-08 1998-03-31 The General Hospital Corporation Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration
FR2688514A1 (en) * 1992-03-16 1993-09-17 Centre Nat Rech Scient Defective recombinant adenoviruses expressing cytokines and antitumour drugs containing them
WO1994003199A1 (en) * 1992-08-04 1994-02-17 Regeneron Pharmaceuticals, Inc. Method of enhancing differentiation and survival of neuronal precursor cells
JPH08501686A (en) * 1992-09-25 1996-02-27 ローン−プーラン・ロレ・ソシエテ・アノニム Adenovirus vector for transfer of foreign gene to cells in central nervous system, especially brain
FR2704234B1 (en) * 1993-04-22 1995-07-21 Centre Nat Rech Scient RECOMBINANT VIRUSES, PREPARATION AND USE IN GENE THERAPY.

Also Published As

Publication number Publication date
JPH09510358A (en) 1997-10-21
FI963674L (en) 1996-09-17
ZA952244B (en) 1996-01-16
IL112992A0 (en) 1995-06-29
EP0750676A1 (en) 1997-01-02
MX9603490A (en) 1997-03-29
WO1995025804A1 (en) 1995-09-28
KR970701784A (en) 1997-04-12
FI963674A7 (en) 1996-09-17
AU1896295A (en) 1995-10-09
CA2184200A1 (en) 1995-09-28
AU703793B2 (en) 1999-04-01
FI963674A0 (en) 1996-09-17
FR2717496A1 (en) 1995-09-22
FR2717496B1 (en) 1996-04-12

Similar Documents

Publication Publication Date Title
FI935058A7 (en) Defective recombinant adenoviruses expressing cytokines for antitumor treatment
FI963805A7 (en) Recombinant adenoviruses encoding glial cell-derived neurotrophic factor (GDNF)
KR970700876A (en) PROJECTOR
FI964833L (en) Pantrophic neurotrophic factors
DE69503375D1 (en) HIGH-RESOLUTION SUBTRACTIVE COLOR PROJECTION SYSTEM
FI965225L (en) New peptides
FI955828A7 (en) New peptide derivatives
FI961350A7 (en) Hapten-tagged peptides
DE69519886D1 (en) Image decoder
GB2291308B (en) Error diffusion image encoding
FI954147L (en) Polypeptides
NO976058L (en) Recombinant Mistakine
FI953302A0 (en) New peptides
DE69736966D1 (en) LCD color projector
FI971499L (en) New peptides with immunomodulatory effects
GB9920063D0 (en) Projector transporter
DE69310280D1 (en) Alumina, calcium oxide, yttria sealant composition
FI970168A0 (en) peptides
NO983849D0 (en) peptide
FI933495L (en) Recombinant adenovirus vaccine
FI964363L (en) Peptides
FI943626L (en) Recombinant adenovirus vaccines
DE69622119D1 (en) color projector
FI953451A7 (en) Carbonation related improvements
AU1896295A (en) Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application